Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging

American Journal of Psychiatry

Volumn 153, Issue 12, 1996, Pages 1554-1563

  Bertolino, Alessandro ^b   Nawroz, Safia ^b   Mattay, Venkata S ^b   Barnett, Alan S ^b   Duyn, Jozef H ^b   Moonen, Chrit T W ^b   Frank, Joseph A ^b   Tedeschi, Gioacchino ^b   Weinberger, Daniel R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; INTERVIEW; MALE; MORPHOMETRICS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA;

EID: 0029853927     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.12.1554     Document Type: Article

References (55)

1. Benes FM, Davidson B, Bird ED: Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics, Arch Gen Psychiatry 1986; 43:31-35
2. Jakob H, Beckman H: Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1989; 65:303-326
3. Falkai P, Bogerts B: Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci 1986; 236:154-161
4. Jeste DV, Lohr JB: Hippocampal pathologic findings in schizophrenia: a morphometric study. Arch Gen Psychiatry 1989; 46: 1019-1024
5. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR: Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991; 48:625-632
6. Roberts GW, Royston MC, Weinberger DR: Schizophrenia, in Greenfield's Neuropathology, 6th ed. Edited by Graham D, Lantos P. London, Edward Arnold (in press)
7. Selemon LD, Rajkowska G, Goldman-Rakic PS: Abnormally high neuronal density in the schizophrenic correx: a morphometric analysis of prefrontal area 9 and occipital area 17, Arch Gen Psychiatry 1995; 52:805-818
8. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR: Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 1990; 322:789-794
9. Bogerts B, Lieberman JA, Ashtari M, Bilder RM, Degreef G, Lerner G, Johns C, Masiar S: Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biol Psychiatry 1993; 33:236-246
10. Marsh L, Suddath R, Higgins N, Weinberger DR: Medial temporal lobe structures in schizophrenia: relationship of size to duration illness. Schizophr Res 1994; 11:225-238
11. Breier A, Buchanan RW, Elkashef A, Munson RC, Kirkpatrick B, Cellad F: Brain morphology and schizophrenia: a magnetic resonance imaging study of limbic prefrontal cortex and caudate structures. Arch Gen Psychiatry 1992; 49:921-926
12. Zipursky RB, Marsh L, Lim KO, DeMent S, Shear PK, Sullivan EV, Murphy GM, Csernansky JG, Pfefferbaum A: Volumetric MRI assessment of temporal lobe structures in schizophrenia. Biol Psychiatry 1994; 35:501-516
13. Andreasen NC, Flashman L, Flaum M, Arndt S, Swayze V II, O'Leary DS, Ehrhardt JC, Yuh WTC: Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA 1994; 272:1763-1769
14. Kelsoe JR, Cadet JL, Pickar D, Weinberger DR: Quantitative neuroanatomy in schizophrenia. Arch Gen Psychiatry 1988; 45:533-541
15. Urenjak J, Williams SR, Gadian DG, Noble M: Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993; 13:981-989
16. Barker PB, Breiter SN, Sober BJ, Chatham JC, Forder JR, Samphilipo MA, Magee CA, Anderson JH: Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 1994; 32:157-163
17. Miller BI.: A review of chemical issues in IH NMR spectroscopy: N-acetyl-1-aspartate, creatine and choline, NMR Biomed 1991; 4:47-52
18. Yurgelun-Todd DA, Renshaw PF, Gruber SA, Ed M, Waternaux C, Cohen BM: Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophr Res 1996; 19:55-59
19. Renshaw PF, Yurgelun-Todd DA, Tohen M, Gruber S, Cohen BM: Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry 1995; 152: 444-446
20. Nasrallah HA, Skinner TE, Schmalbrock P, Robitaille PM: Proton magnetic resonance spectroscopy of the hippocampal formation in schizophrenia: a pilot study. Br J Psychiatry 1994; 165: 481-485
21. Maier M, Ron MA, Barker GJ, Tofts PS: Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol Med 1995; 25: 1201-1209
22. 1H Magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical neurodevelopmental and cognitive correlates. Biol Psychiatry 1994; 36:792-800
23. 1H MRS (abstract). Schizophr Res 1993; 9:210
24. Fukuzako H, Takeuchi K, Hokazono Y, Fukuzako T, Yamada K, Hashiguchi T, Oho Y, Ueyama K, Takigawa M, Fujimuto T: Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Psychiatry Res Neuroimaging 1995; 61:193-200
25. 1H-NMR spectroscopy study of schizophrenics, in Society of Magnetic Resonance Book of Abstracts. Berkeley, Calif, SMR, 1995, p 1846
26. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CTW: Multisection proton MR spectroscopic imaging of the brain. Radiology 1993; 188:277-282
27. Barker PB, Gillard JH, van Zijl PCM, Sober BJ, Hanley DF, Agildere AM, Oppenheimer SM, Bryan RN: Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994; 192:723-732
28. Bizzi A, Movsas B, Tedeschi G, Phillips CL, Okunieff P, Alger JR, Di Chiro G: Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with 1H-MR spectroscopic imaging. Radiology 1995; 194:271-276
29. Barker PB, Lee RR, McArthur J: AIDS dementia complex: evaluation with proton MR spectroscopic imaging. Radiology 1995; 195:58-64
30. Tedesohi G, Bertolino A, Massaquoi S, Campbell G, Patronas NJ, Bonavita S, Barnett AS, Alger JR, Hallett M: Proton magnetic resonance spectroscopic imaging in patients with cerebellar degeneration. Ann Neurol 1996; 39:71-78
31. Kruse B, Barker PB, van Zijl PCM, Duyn JH, Moonen CTW, Moser HW: Multislice proton magnetic resonance spectroscopic imaging in X-linked adrenoleukodystrophy. Ann Neurol 1994; 36:595-608
32. Tedeschi G, Bertolino A, Righini A, Campbell G, Raman R, Duyn JH, Moonen CTW, Alger JR, Di Chiro G: Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 1995; 45:1384-1391
33. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT: Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995; 52:829-836
34. 1H NMR study of postmortem brains of schizophrenics, in Society of Magnetic Resonance Book of Abstracts. Berkeley, Calif, SMR, 1995, p 1845
35. Hetherington H, Mason G, Pan J, Ponder SI., Vaughan JT, Twieg DB, Pohosr GM: Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1 T. Magn Reson Med 1994; 32:565-571
36. Kreis R, Ernst T, Ross B: Absolute quantitation of water and metabolites in the human brain. J Magn Reson 1993; 102:9-19
37. Michaelis T, Merboldt K, Bruhn H, Hanicke W, Frahm J: Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993; 187:219-227
38. Okumura N, Otsuki S, Nasu H: The influence of insulin hypoglycemic coma, repeated electroshocks, and chlorpromazine or beta-phenylisopropylmethylamine administration on the free amino acids in the brain. J Biochem (Tokyo) 1959; 46:247-252
39. Bertolino A, Callicott JH, Elman I, Breier A, Tedeschi G, Frank JA, Pickar D, Weinberger DR: Proton magnetic resonance spectroscopic imaging in drug naive patients with schizophrenia: regionality of neuronal damage, in Society of Magnetic Resonance Book of Abstracts. Berkeley, Calif, SMR, 1996, p 1002
40. Williamson P, Pelz D, Merskey H, Morrison S, Karlik S, Drost D, Carr T, Conlon P: Frontal, temporal, and striatal proton relaxation times in schizophrenic patients and normal comparison subjects. Am J Psychiatry 1992; 149:549-551
41. Strauss WL, Tsuruda JS, Richards TL: Partial volume effects in volume-localized phased-array proton spectroscopy of the temporal lobe. J Magn Reson Imaging 1995; 5:433-436
42. Weinberger DR, Lipska BK: Cortical maldevelopment, antipsychotic drugs, and schizophrenia: a search for common ground. Schizophr Res 1995; 16:87-110
43. Weinberger DR: Anteromedial temporal-prefrontal connectivity: a functional neuroanatomical system implicated in schizophrenia, in Psychopathology and the Brain. Edited by Carroll BJ, Barrett JE. New York, Raven Press, 1991, pp 25-43
44. Friston KJ, Herold S, Fletcher P, Silbersweig D, Cahill C, Dolan RJ, Liddle PF, Frackowiak RSJ, Frith CD: Abnormal frontotemporal interactions in patients with schizophrenia, in Biology of Schizophrenia and Affective Disease. Edited by Watson SJ. Washington, DC, American Psychiatric Press, 1996, pp 421-449
45. Tsai G, Coyle J: N-Acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995; 46:531-540
46. De Stefano N, Matthews P, Antel JP, Preul M, Francis G, Arnold DL: Chemical pathology of acute demyelinating lesions and its correlations with disability. Ann Neurol 1995; 38:901-909
47. Vion-Dury J, Nicoli F, Salvan AM, Confort-Gouny S, Dhiver C, Cozzone P: Reversal of brain metabolic alterations with zidovudine detected by proton localized magnetic resonance spectroscopy. Lancet 1995; 345:60-61
48. Brenner RE, Munro PM, Williams SC, Bell JD, Barker GJ, Hawkins CP, Landon DN, McDonald WI: The proton NMR spectrum in acute EAE: the significance of the change in the Cho: Cr ratio. Magn Reson Med 1993; 29:737-745
49. 1H magnetic resonance spectroscopy study. Magn Reson Med 1995; 33:595-600
50. Stoll A, Renshaw PF, De Micheli E, Wurtmann R, Pillay SS, Cohen B: Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study. Biol Psychiatry 1995; 37:170-174
51. Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG: Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 1994; 44:1411-1417
52. Ng TC, Comair YG, Xue M, So N, Majors A, Kolem H, Luders H, Modic M: Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. Radiology 1994; 193:465-472
53. 1H Magnetic resonance spectroscopy in the investigation of intractable epilepsy. Acta Neurol Scand Suppl 1994; 152:116-121
54. Hetherington H, Kuzniecky R, Pan J, Mason G, Morawetz R, Harris C, Faught E, Vaughan T, Pohost G: Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol 1995; 38:396-404
55. Weinberger DR: From neuropathology to neurodevelopment. Lancet 1995; 346:552-557